Market Research Logo

Global Peptide Therapeutics Sales Market Report 2018

Global Peptide Therapeutics Sales Market Report 2018

This report studies the Peptide Therapeutics market status and outlook of global and major regions, from angles of players, regions, product types and end industries; this report analyzes the top players in global and major regions, and splits the Peptide Therapeutics market by product type and applications.

In the last several years, global market of Peptide Therapeutics developed rapidly, with an average growth rate of 7.7%. In 2017, global revenue of Peptide Therapeutics is nearly 28.5 billion USD; the actual production is about 150 million units.

The major players in global Peptide Therapeutics market include
Sanofi
Teva
Novo Nordisk
Takeda
Eli Lilly
AstraZeneca
Novartis
Shire
AbbVie
Ipsen
Allergan
Ferring
Merck
The Medicines
Roche
J & J

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Peptide Therapeutics in these regions, from 2013 to 2025 (forecast), covering
North America
Europe
China
Japan
India
South America
Rest of World

On the basis of product, the Peptide Therapeutics market is primarily split into
Injection
Oral
Other

On the basis on the end users/applications, this report covers
Cancer
Metabolic Disorders
Central Nervous System
Other


1 Peptide Therapeutics Market Overview
1.1 Product Overview and Scope of Peptide Therapeutics
1.2 Classification of Peptide Therapeutics by Product Category
1.2.1 Global Peptide Therapeutics Revenue Comparison by Types (2013-2025)
1.2.2 Global Peptide Therapeutics Revenue Market Share by Types in 2017
1.2.3 Injection
1.2.4 Oral
1.3 Global Peptide Therapeutics Market by Applications/End Users
1.3.1 Global Peptide Therapeutics Revenue Comparison by Applications (2013-2025)
1.3.2 Cancer
1.3.3 Metabolic Disorders
1.3.4 Central Nervous System
1.4 Global Peptide Therapeutics Market by Regions
1.4.1 Global Peptide Therapeutics Revenue Comparison by Regions (2013-2025)
1.4.2 North America Peptide Therapeutics Status and Prospect (2013-2025)
1.4.3 Europe Peptide Therapeutics Status and Prospect (2013-2025)
1.4.4 China Peptide Therapeutics Status and Prospect (2013-2025)
1.4.5 Japan Peptide Therapeutics Status and Prospect (2013-2025)
1.4.6 India Peptide Therapeutics Status and Prospect (2013-2025)
1.4.7 South America Peptide Therapeutics Status and Prospect (2013-2025)
1.5 Global Peptide Therapeutics Sales and Revenue (2013-2025)
1.5.1 Global Peptide Therapeutics Sales and Growth Rate (2013-2025)
1.5.2 Global Peptide Therapeutics Revenue and Growth Rate (2013-2025)
1.6 Lanreotide Revenue and Growth Rate2013-2025
1.7 Liraglutide Revenue and Growth Rate 2013-2025
2 Global Peptide Therapeutics Competition by Players, Type and Application
2.1 Global Peptide Therapeutics Market Competition by Players
2.1.1 Global Peptide Therapeutics Sales and Market Share of Key Players (2016-2017)
2.1.2 Global Peptide Therapeutics Revenue and Share by Players (2016-2017)
2.2 Global Peptide Therapeutics Sales and Revenue by Type
2.2.1 Global Peptide Therapeutics Sales and Market Share by Type (2013-2018)
2.2.2 Global Peptide Therapeutics Revenue and Market Share by Type (2013-2018)
2.3 Global Peptide Therapeutics Sales and Revenue by Regions
2.3.1 Global Peptide Therapeutics Sales and Market Share by Regions (2013-2018)
2.3.2 Global Peptide Therapeutics Revenue and Market Share by Regions (2013-2018)
2.4 Global Peptide Therapeutics Revenue by Application
3 North America Peptide Therapeutics (Sales, Revenue and Price)
3.1 North America Peptide Therapeutics Sales and Revenue (2013-2018)
3.1.1 North America Peptide Therapeutics Sales and Growth Rate (2013-2018)
3.1.2 North America Peptide Therapeutics Revenue and Growth Rate (2013-2018)
3.1.3 North America Peptide Therapeutics Price Trend (2013-2018)
3.2 North America Peptide Therapeutics Revenue and Market Share by Players
3.3 North America Peptide Therapeutics Revenue and Market Share by Type
3.4 North America Peptide Therapeutics Revenue and Market Share by Application
4 China Peptide Therapeutics (Sales, Revenue and Price)
4.1 China Peptide Therapeutics Sales and Revenue (2013-2018)
4.1.1 China Peptide Therapeutics Sales and Growth Rate (2013-2018)
4.1.2 China Peptide Therapeutics Revenue and Growth Rate (2013-2018)
4.1.3 China Peptide Therapeutics Price Trend (2013-2018)
4.2 China Peptide Therapeutics Revenue and Market Share by Players
4.3 China Peptide Therapeutics Revenue and Market Share by Type
4.4 China Peptide Therapeutics Revenue and Market Share by Application
5 Europe Peptide Therapeutics (Sales, Revenue and Price)
5.1 Europe Peptide Therapeutics Sales and Value (2013-2018)
5.1.1 Europe Peptide Therapeutics Sales and Growth Rate (2013-2018)
5.1.2 Europe Peptide Therapeutics Revenue and Growth Rate (2013-2018)
5.1.3 Europe Peptide Therapeutics Price Trend (2013-2018)
5.2 Europe Peptide Therapeutics Revenue and Market Share by Players
5.3 Europe Peptide Therapeutics Revenue and Market Share by Type
5.4 Europe Peptide Therapeutics Revenue and Market Share by Application
6 Japan Peptide Therapeutics (Sales, Revenue and Price)
6.1 Japan Peptide Therapeutics Sales and Value (2013-2018)
6.1.1 Japan Peptide Therapeutics Sales and Growth Rate (2013-2018)
6.1.2 Japan Peptide Therapeutics Revenue and Growth Rate (2013-2018)
6.1.3 Japan Peptide Therapeutics Price Trend (2013-2018)
6.2 Japan Peptide Therapeutics Revenue and Market Share by Players
6.3 Japan Peptide Therapeutics Revenue and Market Share by Type
6.4 Japan Peptide Therapeutics Revenue and Market Share by Application
7 India Peptide Therapeutics (Sales, Revenue and Price)
7.1 India Peptide Therapeutics Sales and Value (2013-2018)
7.1.1 India Peptide Therapeutics Sales and Growth Rate (2013-2018)
7.1.2 India Peptide Therapeutics Revenue and Growth Rate
7.1.3 India Peptide Therapeutics Price Trend
7.2 India Peptide Therapeutics Revenue and Market Share by Players
7.3 India Peptide Therapeutics Revenue and Market Share by Type
7.4 India Peptide Therapeutics Revenue and Market Share by Application
8 South America Peptide Therapeutics (Sales, Revenue and Price)
8.1 South America Peptide Therapeutics Sales and Value (2013-2018)
8.1.1 South America Peptide Therapeutics Sales and Growth Rate (2013-2018)
8.1.2 South America Peptide Therapeutics Revenue and Growth Rate (2013-2018)
8.1.3 South America Peptide Therapeutics Price Trend
8.2 South America Peptide Therapeutics Revenue and Market Share by Players
8.3 South America Peptide Therapeutics Revenue and Market Share by Type
8.4 South America Peptide Therapeutics Revenue and Market Share by Application
9 Analysis of Peptide Therapeutics Industry Key Manufacturers
9.1 Sanofi
9.1.1 Company Profile
9.1.2 Product Information
9.1.3 Sales, Price, Cost, Gross, and Revenue
9.2 Teva
9.2.1 Company Profile
9.2.2 Product Information
9.2.3 Sales, Price, Cost, Gross, and Revenue
9.3 Novo Nordisk
9.3.1 Company Profile
9.3.2 Product Information
9.3.3 Sales, Price, Cost, Gross, and Revenue
9.4 Takeda
9.4.1 Company Profile
9.4.2 Product Information
9.4.3 Sales, Price, Cost, Gross, and Revenue
9.5 Eli Lilly
9.5.1 Company Profile
9.5.2 Product Information
9.5.3 Sales, Price, Cost, Gross, and Revenue
9.6 AstraZeneca
9.6.1 Company Profile
9.6.2 Product Information
9.6.3 Sales, Price, Cost, Gross, and Revenue
9.7 Novartis
9.7.1 Company Profile
9.7.2 Product Information
9.7.3 Sales, Price, Cost, Gross, and Revenue
9.8 Shire
9.8.1 Company Profile
9.8.2 Product Information
9.8.3 Sales, Price, Cost, Gross, and Revenue
9.9 AbbVie
9.9.1 Company Profile
9.9.2 Product Information
9.9.3 Sales, Price, Cost, Gross, and Revenue
9.10 Ipsen
9.10.1 Company Profile
9.10.2 Product Information
9.10.3 Sales, Price, Cost, Gross, and Revenue
9.11 Allergan
9.11.1 Company Profile
9.11.2 Product Information
9.11.3 Sales, Price, Cost, Gross, and Revenue
9.12 Ferring
9.12.1 Company Profile
9.12.2 Product Information
9.12.3 Sales, Price, Cost, Gross, and Revenue
9.13 Merck
9.13.1 Company Profile
9.13.2 Product Information
9.13.3 Sales, Price, Cost, Gross, and Revenue
9.14 The Medicines
9.14.1 Company Profile
9.14.2 Product Information
9.14.3 Sales, Price, Cost, Gross, and Revenue
9.15 Roche
9.15.1 Company Profile
9.15.2 Product Information
9.15.3 Sales, Price, Cost, Gross, and Revenue
9.16 J & J
9.16.1 Company Profile
9.16.2 Product Information
9.16.3 Sales, Price, Cost, Gross, and Revenue
10 Peptide Therapeutics Manufacturing Cost Analysis
10.1 Peptide Therapeutics R&D Cost Analysis
10.1.1 Clinical Phase Costs
10.1.2 Capitalized Costs
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Other Costs Analysis
10.3 Manufacturing Process Analysis of Peptide Therapeutics
11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Peptide Therapeutics Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Downstream Buyers
12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.3 Distributors/Traders List
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Technology Progress
13.1.2 Peptide Cancer Vaccine by Pipeline
13.2 Consumer Needs/Customer Preference Change
13.2.1 Key Facts
13.2.2 Cancer Incidence and Mortality Analysis
13.3 Economic/Political Environmental Change
14 Global Peptide Therapeutics Market Forecast (2019-2025)
14.1 Global Peptide Therapeutics Sales, Revenue and Price Forecast (2019-2025)
14.1.1 Global Peptide Therapeutics Sales and Growth Rate Forecast (2019-2025)
14.1.2 Global Peptide Therapeutics Revenue and Growth Rate Forecast (2019-2025)
14.1.3 Global Peptide Therapeutics Price and Trend Forecast (2019-2025)
14.2 Global Peptide Therapeutics Sales, Revenue and Growth Rate Forecast by Regions (2019-2025)
14.2.1 Global Peptide Therapeutics Sales and Growth Rate Forecast by Regions (2019-2025)
14.2.2 Global Peptide Therapeutics Revenue and Growth Rate Forecast by Regions (2019-2025)
14.2.3 North America Peptide Therapeutics Sales, Revenue and Growth Rate Forecast (2019-2025)
14.2.4 Europe Peptide Therapeutics Sales, Revenue and Growth Rate Forecast (2019-2025)
14.2.5 China Peptide Therapeutics Sales, Revenue and Growth Rate Forecast (2019-2025)
14.2.6 Japan Peptide Therapeutics Sales, Revenue and Growth Rate Forecast (2019-2025)
14.2.7 India Peptide Therapeutics Sales, Revenue and Growth Rate Forecast (2019-2025)
14.2.8 South America Peptide Therapeutics Sales, Revenue and Growth Rate Forecast (2019-2025)
14.3 Global Peptide Therapeutics Sales Forecast by Type (2019-2025)
14.4 Global Peptide Therapeutics Revenue Forecast by Application (2019-2025)
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer
16.4 Author List
List of Tables and Figures
Figure Product Picture of Peptide Therapeutics
Table The Brands of Major Manufacturers
Table Peptide Drugs in the Global Market
Table Global Peptide Therapeutics Revenue (M USD) Comparison by Types (2013-2025)
Figure Global Peptide Therapeutics Revenue Market Share by Types in 2017
Figure Injection Product Picture
Figure Oral Product Picture
Table Global Peptide Therapeutics Revenue (M USD) Comparison by Applications (2013-2025)
Figure Global Revenue Market Share of Peptide Therapeutics by Applications in 2017
Figure Cancer Examples
Figure Metabolic Disorders Examples
Figure Central Nervous System Examples
Table Global Market Peptide Therapeutics Revenue (M USD) Comparison by Regions 2013-2025
Figure North America Peptide Therapeutics Revenue (M USD) and Growth Rate (2013-2025)
Figure Europe Peptide Therapeutics Revenue (M USD) and Growth Rate (2013-2025)
Figure China Peptide Therapeutics Revenue (M USD) and Growth Rate (2013-2025)
Figure Japan Peptide Therapeutics Revenue (M USD) and Growth Rate (2013-2025)
Figure India Peptide Therapeutics Revenue (M USD) and Growth Rate (2013-2025)
Figure South America Peptide Therapeutics Revenue (M USD) and Growth Rate (2013-2025)
Figure Global Peptide Therapeutics Sales (K Unit) and Growth Rate (2013-2025)
Figure Global Peptide Therapeutics Revenue (M USD) and Growth Rate (2013-2025)
Figure Lanreotide Revenue and Growth Rate2013-2025
Figure Liraglutide Revenue and Growth Rate 2013-2025
Table Global Peptide Therapeutics Sales (K Unit) of Key Players (2016-2017)
Table Global Peptide Therapeutics Sales Share (%) by Players (2016-2017)
Figure 2016 Global Peptide Therapeutics Sales Share (%) by Players
Figure 2017 Global Peptide Therapeutics Sales Share (%) by Players
Table Global Peptide Therapeutics Revenue (M USD) by Players (2016-2017)
Table Global Peptide Therapeutics Revenue Share (%) by Players (2016-2017)
Figure 2016 Global Peptide Therapeutics Revenue Share (%) by Players
Figure 2017 Global Peptide Therapeutics Revenue Share (%) by Players
Table Global Peptide Therapeutics Sales (K Unit) by Type (2013-2018)
Table Global Peptide Therapeutics Sales Share (%) by Type (2013-2018)
Figure Sales Market Share (%) of Peptide Therapeutics by Type (2013-2018)
Figure Global Peptide Therapeutics Sales Growth Rate by Type in 2017
Table Global Peptide Therapeutics Revenue (M USD) by Type (2013-2018)
Table Global Peptide Therapeutics Revenue Share (%) by Type (2013-2018)
Figure Revenue Market Share (%) of Peptide Therapeutics by Type (2013-2018)
Figure Global Peptide Therapeutics Revenue Growth Rate by Type in 2017
Table Global Peptide Therapeutics Sales (K Unit) by Regions (2013-2018)
Table Global Peptide Therapeutics Sales Share (%) by Regions (2013-2018)
Figure Sales Market Share (%) of Peptide Therapeutics by Regions (2013-2018)
Figure Global Peptide Therapeutics Sales Market Share (%) by Regions in 2017
Table Global Peptide Therapeutics Revenue (M USD) by Regions (2013-2018)
Table Global Peptide Therapeutics Revenue Share (%) by Regions (2013-2018)
Figure Revenue Market Share (%) of Peptide Therapeutics by Re

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report